Biologics: Investing in the Future of Canadian Healthcare
Investing in Biologics Revolutionizes Canada’s Healthcare Future For decades, the cornerstone of medicine has been small-molecule drugs—think aspirin or statins. These are chemically synthesized, relatively simple compounds that treat symptoms or manage conditions. But a profound shift is underway, moving us from broad-spectrum treatments to highly targeted, living-cell-based therapies. This is the era of biologics, […]
Biologics: Investing in the Future of Canadian Healthcare Read More »










